Pharmaceuticals

Opioids Market 2026 projected to reach $28.59 billion by 2030 with moderate growth at 3.8% CAGR

March 23, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Opioids Market Over The 2026–2030 Period?

The size of the opioids market has shown consistent expansion over recent years. It is projected to increase from $23.98 billion in 2025 to $24.63 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 2.7%. Key factors driving this historical growth include the prevalence of post-surgical pain, an increase in cancer incidence, common opioid prescription practices, the restricted availability of alternative pain treatments, and significant opioid utilization within hospitals.

The opioids market size is anticipated to experience consistent growth in the upcoming years. It is projected to achieve a valuation of $28.59 billion by 2030, expanding at a compound annual growth rate (CAGR) of 3.8%. The growth during this forecast period can be attributed to an increase in the chronic pain population, the development of safer opioid formulations, the expansion of palliative care services, greater regulatory clarity for controlled substances, and the rising demand for effective pain management among aging populations. Significant trends foreseen in the forecast period include the advancement of precision-guided opioid therapy, the integration of digital prescription monitoring, a shift towards abuse-deterrent formulations, the wider availability of long-acting and extended-release opioids, and their growing utilization in oncology pain management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

What Underlying Factors Are Accelerating The Growth Of The Opioids Market?

The future expansion of the opioids market is anticipated to be driven by the rising incidence of chronic diseases. These conditions, also referred to as non-communicable diseases (NCDs), are long-lasting medical issues that typically advance gradually and persist over extended periods, often lasting for years or even a lifetime without self-resolution. The growing number of individuals affected by chronic diseases is a primary contributor to the demand within the opioids market. As more people experience chronic pain associated with these conditions, the need for opioids increases. Opioid application in managing chronic diseases is a intricate and developing field of medicine, known for its effectiveness in alleviating pain. For instance, in June 2024, data from the National Health Service, a UK-based government department, indicated that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition characterized by elevated blood sugar levels, not high enough to be classified as diabetes) in 2023. This represented an 18% surge from 3,065,825 cases recorded in 2022. Consequently, the increasing prevalence of chronic diseases is propelling the growth of the opioids market.

How Is The Opioids Market Segmented Across Key Categories?

The opioids market covered in this report is segmented –

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

Subsegments:

1) By Methadone: Methadone Tablets, Methadone Oral Solution

2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

Which Upcoming Trends Are Expected To Influence The Opioids Market?

Major companies operating within the opioid market are dedicated to developing advanced drug solutions to reinforce their position. The discovery of new medications has the capacity to treat diseases, thereby improving healthcare and scientific knowledge. For instance, in May 2023, Braeburn Pharmaceuticals Inc., a US-based provider of treatments for opioid addiction, announced that the US Food and Drug Administration had approved Brixadi (buprenorphine) extended-release injectable for subcutaneous use (beneath the skin) for the treatment of moderate to severe opioid use disorder (OUD). This marks the initial and only weekly and monthly subcutaneous injection for moderate to severe OUD and the first buprenorphine injectable to utilize FluidCrystal Injection Depot Technology. Patients who are currently receiving oral buprenorphine-containing medications can transition to equivalent dosages if the prescribed advice is followed.

Who Are The Dominant Players Shaping The Opioids Market Landscape?

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca Plc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals plc, Alkermes plc, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

Read the full opioids market report here:

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Which Region Is Projected To Dominate The Opioids Market During The Forecast Period?

North America was the largest region in the opioids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Opioids Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13021&type=smp

Browse Through More Reports Similar to the Global Opioids Market 2026, By The Business Research Company

Opioids Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Morphine Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/morphine-drugs-global-market-report

Opioid Use Disorder Oud Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795